Office (925) 480-7497
Mobile (925) 413-7297

Title Banner

About the Company's mission

Bay Clinical R&D Services aims to assist pharmaceutical and biotechnology companies in all aspects of clinical development.  The President of the company, Anastassios D. Retzios, Ph.D. has extensive experience in the development of drugs and biologics, in clinical study operations, in the writing and compilation of NDAs and interactions with a number of regulatory agencies.

About Anastassios D. Retzios, Ph.D.

Anastassios D. Retzios, the Founder and President of Bay Clinical R&D Services, has extensive experience in clinical operations and pharmaceutical development.  In his early career, in an academia/industry collaborative environment, he participated in the discovery and development of biologic therapeutic agents; later, he served in a variety of leading roles in the industry: as a Clinical Project Manager and Associate Director of Clinical R&D at Alpha Therapeutic Corporation; Senior Director of Clinical R&D at Questcor Pharmaceuticals; Global Director of Clinical Development at Baxter and Vice President of Clinical Development at AP Pharma, Inc.  In his career, he has developed substantial expertise in:

  • The conduct of clinical trials in all phases of development (Phase 1 through 4) in the US, Europe, Asia and Latin America
  • The management of teams of clinical development professionals
  • The authoring of protocols, investigator brochures, clinical study reports and all other documentation required for the filing of successful applications to regulatory authorities in various countries.
  • Interactions with regulatory agencies in the US, Europe and Japan
  • The formulation of development strategy in various therapeutic areas
  • The assessment of product portfolios
  • The due diligence process and demands in mergers and product acquisitions